Home Studies Solution Vaccine Work Background Contact Us
 
 
 
Xpention Genetics, Inc. is a biotechnology company that was formed to develop both immunological and molecular tests for cancer detection in animals and humans as well as therapeutic vaccines and other treatment methods for both veterinary and human cancers. Xpention through its subsidiary has licensed, exclusive rights to a specific genetic marker called the p65 that has highly specific correlation to numerous cancers.
 
 
 
     
    Patents Licensed
     
Patent : 5,773,215 > Download Word Document
Patent : 5,310653 > Download Word Document
Patent : 5,411,868 > Download Word Document

 


Copyright ©2005 Xpention Genetics, Inc.